See more : Regency Investments Limited (REGENCY.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Pfizer Inc. (PFE.F) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Pfizer Inc., a leading company in the Drug Manufacturers – General industry within the Healthcare sector.
- Magontec Limited (MGL.AX) Income Statement Analysis – Financial Results
- Nissou Co.,Ltd. (1444.T) Income Statement Analysis – Financial Results
- China Nature Energy Technology Holdings Limited (1597.HK) Income Statement Analysis – Financial Results
- indie Semiconductor, Inc. (INDI) Income Statement Analysis – Financial Results
- SILVERspac Inc. (SLVRW) Income Statement Analysis – Financial Results
Pfizer Inc. (PFE.F)
About Pfizer Inc.
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1985 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 58.50B | 100.33B | 81.29B | 41.91B | 51.75B | 53.65B | 52.55B | 52.82B | 48.85B | 49.61B | 51.58B | 58.99B | 67.43B | 67.81B | 50.01B | 48.30B | 48.42B | 48.37B | 51.30B | 52.52B | 45.19B | 32.37B | 32.26B | 29.57B | 16.20B | 13.54B | 12.50B | 11.31B | 10.02B | 8.28B | 7.48B | 7.23B | 6.95B | 6.41B | 5.67B | 5.39B | 4.92B | 4.48B | 4.02B |
| Cost of Revenue | 24.95B | 34.34B | 30.82B | 8.69B | 10.22B | 11.25B | 11.24B | 12.33B | 9.65B | 9.58B | 9.59B | 11.33B | 15.09B | 16.28B | 8.89B | 8.11B | 11.24B | 7.64B | 8.53B | 7.54B | 9.83B | 4.05B | 5.03B | 4.06B | 1.99B | 1.61B | 1.77B | 1.75B | 1.79B | 1.63B | 1.51B | 1.76B | 1.96B | 2.03B | 1.86B | 1.83B | 1.73B | 1.57B | 1.42B |
| Gross Profit | 33.54B | 65.99B | 50.47B | 33.22B | 41.53B | 42.40B | 41.31B | 40.50B | 39.20B | 40.03B | 42.00B | 47.65B | 52.34B | 51.53B | 41.12B | 40.18B | 37.18B | 40.73B | 42.77B | 44.98B | 35.36B | 28.33B | 27.23B | 25.52B | 14.22B | 11.94B | 10.73B | 9.56B | 8.23B | 6.65B | 5.96B | 5.47B | 4.99B | 4.37B | 3.82B | 3.56B | 3.18B | 2.90B | 2.61B |
| Gross Profit Ratio | 57.34% | 65.77% | 62.08% | 79.26% | 80.25% | 79.03% | 78.61% | 76.66% | 80.25% | 80.69% | 81.42% | 80.79% | 77.63% | 75.99% | 82.23% | 83.20% | 76.79% | 84.21% | 83.38% | 85.64% | 78.24% | 87.51% | 84.40% | 86.28% | 87.74% | 88.15% | 85.83% | 84.56% | 82.14% | 80.36% | 79.76% | 75.65% | 71.85% | 68.24% | 67.29% | 66.10% | 64.74% | 64.85% | 64.81% |
| Research & Development | 10.68B | 11.43B | 13.83B | 9.41B | 8.65B | 8.01B | 7.66B | 7.87B | 7.69B | 8.39B | 6.68B | 7.87B | 9.11B | 9.41B | 7.85B | 7.95B | 8.09B | 7.60B | 7.44B | 7.68B | 7.13B | 5.18B | 4.85B | 4.44B | 2.78B | 2.28B | 1.93B | 1.57B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 11.07B | 10.88B | 10.70B | 9.82B | 12.05B | 11.76B | 11.68B | 11.64B | 11.71B | 11.00B | 11.36B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 3.70B | 2.80B | 2.00B | 1.80B | 2.30B | 2.70B | 3.10B | 3.20B | 3.10B | 3.10B | 3.00B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 14.77B | 13.68B | 12.70B | 11.62B | 14.35B | 14.46B | 14.78B | 14.84B | 14.81B | 14.10B | 14.36B | 16.62B | 19.47B | 19.61B | 14.88B | 14.54B | 15.63B | 15.59B | 17.00B | 16.90B | 15.24B | 10.85B | 11.30B | 11.44B | 6.35B | 5.57B | 4.96B | 6.05B | 5.30B | 4.39B | 4.79B | 3.76B | 3.50B | 3.09B | 2.64B | 2.35B | 2.08B | 1.80B | 1.60B |
| Other Expenses | 4.73B | 2.07B | 4.09B | 1.50B | 972.00M | 1.14B | 981.00M | 820.00M | 519.00M | 1.27B | 558.00M | -4.03B | 368.00M | 726.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 30.18B | 28.71B | 30.23B | 24.46B | 27.61B | 27.35B | 27.20B | 26.77B | 26.23B | 26.53B | 25.63B | 29.66B | 34.17B | 37.37B | 25.89B | 25.15B | 26.84B | 26.45B | 27.85B | 27.95B | 24.56B | 16.05B | 16.25B | 16.85B | 9.67B | 8.34B | 7.39B | 6.48B | 5.67B | 4.68B | 5.05B | 4.03B | 3.74B | 3.32B | 2.85B | 2.55B | 2.24B | 1.94B | 1.73B |
| Cost & Expenses | 55.14B | 63.06B | 61.05B | 33.15B | 37.83B | 38.60B | 38.44B | 39.09B | 35.88B | 36.11B | 35.22B | 41.00B | 49.25B | 53.65B | 34.78B | 33.26B | 38.08B | 34.09B | 36.37B | 35.49B | 34.39B | 20.10B | 21.28B | 20.90B | 11.66B | 9.94B | 9.16B | 8.23B | 7.46B | 6.31B | 6.56B | 5.79B | 5.70B | 5.35B | 4.70B | 4.37B | 3.98B | 3.52B | 3.14B |
| Interest Income | 1.62B | 251.00M | 36.00M | 73.00M | 226.00M | 333.00M | 391.00M | 470.00M | 471.00M | 425.00M | 403.00M | 383.00M | 458.00M | 402.00M | 746.00M | 1.29B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 2.21B | 1.24B | 1.29B | 1.45B | 1.57B | 1.32B | 1.27B | 1.19B | 1.20B | 1.36B | 1.41B | 1.52B | 1.68B | 1.80B | 1.23B | 516.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 6.29B | 5.06B | 5.19B | 4.78B | 5.76B | 6.15B | 6.27B | 5.76B | 3.73B | 4.04B | 4.60B | 5.18B | 5.59B | 8.49B | 2.88B | 5.09B | 5.20B | 5.29B | 5.58B | 5.09B | 4.08B | 1.04B | 1.07B | 968.00M | 542.00M | 489.00M | 502.00M | 430.00M | 374.00M | 292.00M | 258.20M | 263.90M | 244.10M | 224.80M | 207.10M | 194.50M | 162.00M | 147.10M | 129.50M |
| EBITDA | 9.56B | 43.64B | 30.79B | 13.26B | 18.65B | 11.06B | 19.84B | 19.08B | 17.69B | 19.14B | 23.54B | 25.05B | 29.17B | 23.05B | 22.51B | 15.30B | 17.69B | 21.27B | 24.16B | 25.13B | 22.49B | 13.93B | 12.96B | 12.70B | 5.19B | 5.10B | 4.11B | 3.79B | 3.20B | 2.38B | 1.13B | 1.51B | 1.68B | 1.10B | 1.10B | 1.03B | 969.40M | 1.05B | 929.70M |
| EBITDA Ratio | 16.34% | 43.50% | 35.10% | 33.56% | 38.16% | 39.91% | 38.51% | 36.11% | 36.22% | 38.77% | 42.51% | 42.46% | 43.27% | 33.99% | 45.02% | 54.32% | 36.54% | 43.96% | 47.10% | 47.86% | 49.77% | 43.02% | 40.19% | 42.94% | 32.04% | 37.66% | 32.84% | 33.49% | 31.88% | 28.69% | 15.07% | 20.92% | 24.13% | 17.12% | 19.41% | 19.16% | 19.70% | 23.37% | 23.10% |
| Operating Income | 3.36B | 40.03B | 24.83B | 10.63B | 15.14B | 16.52B | 15.48B | 15.02B | 13.97B | 15.19B | 17.33B | 19.87B | 23.59B | 14.56B | 19.64B | 21.15B | 12.49B | 15.97B | 18.59B | 20.04B | 18.41B | 12.89B | 11.90B | 11.73B | 4.65B | 4.61B | 3.60B | 3.36B | 2.82B | 2.08B | 868.70M | 1.25B | 1.43B | 871.80M | 893.90M | 837.50M | 807.40M | 899.00M | 800.20M |
| Operating Income Ratio | 5.74% | 39.90% | 30.55% | 25.37% | 29.25% | 30.79% | 29.46% | 28.43% | 28.59% | 30.63% | 33.59% | 33.69% | 34.98% | 21.47% | 39.27% | 43.78% | 25.80% | 33.02% | 36.23% | 38.16% | 40.75% | 39.82% | 36.88% | 39.67% | 28.70% | 34.05% | 28.82% | 29.68% | 28.15% | 25.16% | 11.62% | 17.27% | 20.62% | 13.61% | 15.76% | 15.55% | 16.41% | 20.08% | 19.88% |
| Total Other Income/Expenses | -2.30B | -2.54B | -523.00M | -1.79B | -3.82B | -3.14B | -1.77B | -5.36B | -4.01B | -2.95B | -650.00M | -5.83B | -5.33B | -7.09B | -4.89B | -1.90B | -1.06B | -1.25B | -3.41B | -3.03B | -7.10B | -425.00M | -630.00M | -2.80B | -17.00M | -217.00M | -526.00M | -558.00M | -268.00M | -115.60M | -64.50M | 283.50M | -313.00M | 227.30M | -55.80M | 263.20M | 200.10M | 61.70M | -3.90M |
| Income Before Tax | 1.06B | 34.73B | 24.31B | 7.50B | 17.68B | 11.89B | 12.31B | 8.35B | 8.97B | 12.24B | 15.72B | 12.08B | 12.76B | 9.42B | 10.83B | 9.69B | 9.28B | 13.03B | 11.53B | 14.01B | 3.26B | 11.80B | 10.33B | 5.77B | 4.44B | 2.59B | 3.08B | 2.80B | 2.29B | 1.86B | 848.80M | 1.53B | 940.50M | 1.10B | 912.40M | 1.10B | 1.01B | 960.70M | 876.10M |
| Income Before Tax Ratio | 1.81% | 34.61% | 29.91% | 17.89% | 34.17% | 22.15% | 23.42% | 15.81% | 18.35% | 24.67% | 30.47% | 20.48% | 18.93% | 13.89% | 21.65% | 20.07% | 19.16% | 26.93% | 22.48% | 26.67% | 7.22% | 36.44% | 32.02% | 19.50% | 27.42% | 19.14% | 24.62% | 24.75% | 22.87% | 22.42% | 11.35% | 21.19% | 13.53% | 17.16% | 16.09% | 20.44% | 20.48% | 21.46% | 21.77% |
| Income Tax Expense | -1.12B | 3.33B | 1.85B | 477.00M | 1.38B | 706.00M | -9.05B | 1.12B | 1.99B | 3.12B | 4.31B | 2.56B | 4.02B | 1.12B | 1.65B | 1.65B | 1.02B | 1.99B | 3.42B | 2.67B | 1.62B | 2.61B | 2.56B | 2.05B | 1.24B | 642.00M | 865.00M | 869.00M | 738.00M | 558.50M | 191.30M | 438.60M | 218.40M | 297.90M | 231.30M | 309.40M | 317.30M | 300.70M | 296.40M |
| Net Income | 2.12B | 31.37B | 21.98B | 9.16B | 16.03B | 11.15B | 21.31B | 7.21B | 6.96B | 9.13B | 22.00B | 14.57B | 10.01B | 8.26B | 8.64B | 8.10B | 8.14B | 19.33B | 8.08B | 11.36B | 3.91B | 9.13B | 7.79B | 3.73B | 3.18B | 3.35B | 2.21B | 1.93B | 1.57B | 1.30B | 657.50M | 810.90M | 722.10M | 801.20M | 681.10M | 791.30M | 690.20M | 660.00M | 579.70M |
| Net Income Ratio | 3.62% | 31.27% | 27.04% | 21.86% | 30.97% | 20.79% | 40.55% | 13.66% | 14.24% | 18.41% | 42.65% | 24.70% | 14.84% | 12.17% | 17.27% | 16.78% | 16.81% | 39.97% | 15.75% | 21.62% | 8.64% | 28.19% | 24.14% | 12.60% | 19.62% | 24.74% | 17.70% | 17.06% | 15.70% | 15.68% | 8.79% | 11.22% | 10.39% | 12.51% | 12.01% | 14.69% | 14.03% | 14.75% | 14.40% |
| EPS | 0.37 | 5.59 | 3.92 | 1.65 | 2.92 | 1.90 | 3.57 | 1.18 | 1.13 | 1.44 | 3.23 | 1.96 | 1.28 | 1.03 | 1.23 | 1.20 | 1.18 | 2.67 | 1.10 | 1.51 | 0.54 | 1.48 | 1.25 | 0.60 | 0.52 | 0.55 | 0.58 | 0.52 | 0.42 | 0.35 | 0.17 | 0.21 | 0.19 | 0.21 | 0.16 | 0.19 | 0.17 | 0.16 | 0.14 |
| EPS Diluted | 0.37 | 5.47 | 3.85 | 1.63 | 2.87 | 1.87 | 3.52 | 1.17 | 1.11 | 1.42 | 3.19 | 1.94 | 1.27 | 1.02 | 1.23 | 1.20 | 1.17 | 2.66 | 1.09 | 1.49 | 0.54 | 1.46 | 1.22 | 0.59 | 0.50 | 0.53 | 0.56 | 0.50 | 0.42 | 0.35 | 0.17 | 0.20 | 0.18 | 0.21 | 0.16 | 0.19 | 0.17 | 0.16 | 0.14 |
| Weighted Avg Shares Out | 5.73B | 5.61B | 5.60B | 5.56B | 5.57B | 5.87B | 5.97B | 6.09B | 6.18B | 6.35B | 6.81B | 7.44B | 7.82B | 8.04B | 7.01B | 6.73B | 6.92B | 7.24B | 7.36B | 7.53B | 7.21B | 6.16B | 6.24B | 6.21B | 6.13B | 6.12B | 3.82B | 3.71B | 3.77B | 3.72B | 3.87B | 3.86B | 3.80B | 3.82B | 4.26B | 4.16B | 4.06B | 4.13B | 4.14B |
| Weighted Avg Shares Out (Dil) | 5.71B | 5.73B | 5.71B | 5.63B | 5.68B | 5.98B | 6.06B | 6.16B | 6.26B | 6.42B | 6.90B | 7.51B | 7.87B | 8.07B | 7.05B | 6.75B | 6.94B | 7.27B | 7.41B | 7.61B | 7.29B | 6.24B | 6.36B | 6.37B | 6.32B | 6.36B | 3.95B | 3.86B | 3.77B | 3.72B | 3.87B | 4.05B | 4.01B | 3.82B | 4.26B | 4.16B | 4.06B | 4.13B | 4.14B |
Source: https://incomestatements.info
Category: Stock Reports